gms | German Medical Science

80th Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

20.05. - 24.05.2009, Rostock

Metachrone sinunasal carcinoma after laryngectomy

Meeting Abstract

Search Medline for

  • corresponding author Antoniu Gostian - Städt. Kliniken Neuss, Neuss, Germany
  • Andreas Neumann - Städt. Kliniken Neuss, Neuss, Germany
  • Thoralf Stange - Städt. Kliniken Neuss, Neuss, Germany

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery. 80th Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery. Rostock, 20.-24.05.2009. Düsseldorf: German Medical Science GMS Publishing House; 2009. Doc09hno057

DOI: 10.3205/09hno057, URN: urn:nbn:de:0183-09hno0572

Published: July 22, 2009

© 2009 Gostian et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Introduction: The incidence of metachrone secondary carcinoma after squamos cell carcinoma of the upper aerodigestiv tract averages 15%. Secondary carcinoma within the nasal cavity and the paranasal sinuses account for only 1%. They are commonly diagnosed at advance stages leading to considerably worse outcome. The pathophysiological alterations after laryngectomy account for the concealed clinical symptoms and display a real challenge in oncological follow up of these patients. In this study we present our clinical experience with metachrone sinunasal carcinoma after laryngectomy in regard to the spare literature on this topic.

Patients and methods: In a retrospective analysis we reviewed the charts of all patients in our department that developed a metachrone sinunasal carcinoma after laryngectomy.

Results: From 2003 to 2008 five patients developed metachrone sinunasal carcinomas 7 months to 38 years after laryngectomy. Epistaxis and facial pain or pressure were the major complaints. Three patients presented with a secondary tumour in the nasal cavity and two patients developed carcinomas of the maxillary sinus. All secondary carcinomas were diagnosed at stage T3 or T4. Only one patient was suitable for curative tumor resection. In one patient R1-resection of the tumour was feasible and three patients were eligible for primary radiochemotherapy. Overall survival after treatment of the second malignancy varied from 6 to 20 months.

Conclusion: Metachrone sinunasal carcinomas are diagnosed at advanced stages. This may be due to occult early clinical symptoms such as nasal obstruction, rhinorrhea oder hyposmia that cannot be sensed by laryngectomized patients. In most cases there are no curative treatment options at the time of diagnosis. Therefore the oncological follow up of patients after laryngectomy should include a thoroughly endoscopic examination of the nasal cavity and the paranasal sinuses even when sinunasal symptoms are not present.


References

1.
Spector J, et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope. 2001;111(6):1079-87.
2.
Wolpoe M, et al. Squamous cell carcinoma of the sinonasal cavity arising as a second primary in individuals with head and neck cancer. Laryngoscope. 2006;116(5):696-9.
3.
Morinière S, et al. Metachronous sinonasal squamous-cell carcinoma after pharyngolaryngectomy. Ann Otolaryngol Chir Cervicofac. 2004;121(4):241-4.